cobalt has been researched along with Coronary Restenosis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, J; Awata, M; Kashiwabara, K; Kimura, T; Kozuma, K; Matsuyama, Y; Nanasato, M; Oba, K; Shinozaki, T; Shiode, N; Tanabe, K; Yamaguchi, J | 1 |
| Angiolillo, DJ; Baber, U; Bangalore, S; Bhatt, DL; Chandiramani, R; Claessen, BE; Ge, J; Guedeney, P; Hermiller, J; Kozuma, K; Krucoff, M; Liu, Y; Makkar, R; Mehran, R; Neumann, FJ; Rau, V; Saito, S; Seth, A; Sorrentino, S; Valgimigli, M; Vogel, B; Wang, J | 1 |
| Aizawa, Y; Fujita, S; Fuse, K; Hatada, K; Ikeda, Y; Kishi, S; Matsubara, T; Okabe, M; Sato, T; Takahashi, M | 1 |
| Addad, A; Blanchemain, N; Chai, F; Courcot, E; Haulon, S; Laure, W; Lyskawa, J; Martel, B; Simon, N; Sobocinski, J; Taha, M; Woisel, P | 1 |
| Beleslin, B; Carrie, D; Danzi, GB; Iniguez, A; Macaya, C; Mehmedbegovic, Z; Moreno, R; Putnikovic, B; Schächinger, V; Zeymer, U | 1 |
| Ahn, DJ; Han, DK; Joung, YK; Jung, JW; Lih, E | 1 |
| Fraccaro, C; Grossi, P; Mariani, L; Moretti, L; Silenzi, S; Vagnarelli, F | 1 |
| Eda, T; Hayashi, K; Ishiki, R; Miyake, Y; Suga, K; Teshima, Y; Umeda, H | 1 |
| Chen, C; Chung, SM; Kong, X; Lee, IS; Luo, D; Yang, J; Yao, C | 1 |
| Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Kandzari, DE; Leon, MB; Miyazawa, A; Sakurai, R; Tsujino, I; Waseda, K; Yock, PG | 1 |
| Airoldi, F; Briguori, C; Focaccio, A; Tavano, D; Visconti, G | 1 |
| Abdel-Wahab, M; Geist, V; Kassner, G; Klatt, L; Richardt, G; Sherif, MA; Toelg, R | 1 |
| Agostoni, P; Belkacemi, A; Doevendans, PA; Nathoe, HM; Politi, L; Sangiorgi, GM; Shao, C; Stella, PR; Van Belle, E; Voskuil, M; Wildbergh, T | 1 |
| Horton, JL; Mourtada, F | 1 |
| Bhargava, B; Karthikeyan, G; Mishra, S; Raju, R; Reddy, NK; Singh, S; Somaraju, B; Virmani, R; Waksman, R | 1 |
| Baffour, R; Hellinga, D; Pakala, R; Seabron, R; Tio, FO; Waksman, R | 1 |
3 trial(s) available for cobalt and Coronary Restenosis
| Article | Year |
|---|---|
Cobalt-chromium KAname™ coRonary stEnt system in the treatment of patients with coronary artery disease (KARE study).
Topics: Aged; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; France; Humans; Hyperplasia; Male; Middle Aged; Neointima; Prospective Studies; Stents | 2014 |
Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Topics: Aged; Alloys; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Cobalt; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Phosphorylcholine; Prosthesis Design; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional; United States | 2009 |
First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary p
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Research Design; Risk Assessment; Risk Factors; Single-Blind Method; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2012 |
13 other study(ies) available for cobalt and Coronary Restenosis
| Article | Year |
|---|---|
Impact of Residual Stenosis on the Angiographic Edge Restenosis of a Second-Generation Drug-Eluting Stent.
Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Equipment Failure Analysis; Female; Hospitals, University; Humans; Incidence; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Product Surveillance, Postmarketing; Prognosis; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Sirolimus; Survival Analysis; Treatment Outcome | 2019 |
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
Topics: Aged; Aged, 80 and over; Cause of Death; Chromium; Cobalt; Comorbidity; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Hemorrhage; Hemorrhagic Disorders; Humans; Kaplan-Meier Estimate; Male; Metabolic Syndrome; Middle Aged; Mortality; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymers; Prevalence; Proportional Hazards Models; Prospective Studies; Registries; Smoking; Treatment Outcome | 2020 |
Comparison of clinical outcomes of coronary artery stent implantation in patients with end-stage chronic kidney disease including hemodialysis for three everolimus eluting (EES) stent designs: Bioresorbable polymer-EES, platinum chromium-EES, and cobalt c
Topics: Absorbable Implants; Aged; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Renal Dialysis; Risk Factors; Trace Elements; Treatment Outcome | 2018 |
Mussel inspired coating of a biocompatible cyclodextrin based polymer onto CoCr vascular stents.
Topics: Animals; Biocompatible Materials; Bivalvia; Cellulose; Chromium; Cobalt; Coronary Restenosis; Cyclodextrins; Drug Delivery Systems; Drug-Eluting Stents; Humans; Microvessels; Paclitaxel | 2014 |
Synergistic effect of anti-platelet and anti-inflammation of drug-coated Co-Cr substrates for prevention of initial in-stent restenosis.
Topics: Anti-Inflammatory Agents; Aspirin; Cells, Cultured; Chromium Alloys; Cobalt; Coronary Restenosis; Drug Liberation; Drug Synergism; Drug-Eluting Stents; Humans; Microscopy, Electron, Scanning; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Polyesters; Prasugrel Hydrochloride; Propolis; Sirolimus | 2016 |
Effect on Clinical Restenosis of an Ultra-Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Thin-Strut Stainless Steel Stent.
Topics: Aged; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Stainless Steel; Stents; Treatment Outcome | 2016 |
[Coronary Artery Bypass Grafting for In-stent Restenosis Probably Caused by Allergic Response;Report of a Case].
Topics: Cobalt; Coronary Artery Bypass, Off-Pump; Coronary Restenosis; Device Removal; Drug-Eluting Stents; Eosinophils; Female; Humans; Hypersensitivity; Macrophages; Middle Aged; Myocardial Infarction; Nickel; Treatment Failure; Treatment Outcome | 2016 |
Biomimetic apatite formed on cobalt-chromium alloy: A polymer-free carrier for drug eluting stent.
Topics: Apatites; Arteries; Biomimetic Materials; Cell Adhesion; Cell Proliferation; Chromium Alloys; Cobalt; Coronary Restenosis; Drug Delivery Systems; Drug-Eluting Stents; Humans; Myocytes, Smooth Muscle; Polymers; Porosity; Sirolimus; Surface Properties; X-Ray Diffraction | 2017 |
The CID Chrono cobalt-chromium alloy carbofilm-coated coronary stent system.
Topics: Aged; Angioplasty, Balloon, Coronary; Biocompatible Materials; Chromium Alloys; Cobalt; Coronary Artery Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Registries; Stents | 2011 |
Long-term clinical outcome of thin-strut cobalt-chromium stents in the drug-eluting stent era: results of the COBALT (comparison of bare-metal stents in all-comers' lesion treatment) registry.
Topics: Aged; Chromium; Cobalt; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Prospective Studies; Registries; Statistics as Topic; Time Factors; Treatment Outcome | 2011 |
Dose perturbation of a novel cobalt chromium coronary stent on 32P intravascular brachytherapy: a monte carlo study.
Topics: Brachytherapy; Chromium; Cobalt; Coronary Disease; Coronary Restenosis; Humans; Monte Carlo Method; Phosphorus Radioisotopes; Radiometry; Software; Time Factors | 2005 |
A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
Topics: Analysis of Variance; Animals; Carbon; Chromium; Coated Materials, Biocompatible; Cobalt; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Lactic Acid; Nanostructures; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Stents; Swine | 2006 |
Short-term effects of biocorrodible iron stents in porcine coronary arteries.
Topics: Animals; Biocompatible Materials; Chromium; Cobalt; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Fibrin; Inflammation; Iron Compounds; Stents; Swine | 2008 |